Connect Biopharma Holdings Ltd

CNTB · Nasdaq · SIC 2834: Pharmaceutical Preparations
72
SEC Filings

Business Summary

. Overview Connect Biopharma, headquartered in San Diego, California, is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The Company is advancing rademikibart, a next-generation, potentially best-in-class antibody designed to target interleukin-4-receptor alpha (IL-4R). Significant Unmet Need and Market Opportunity in Asthma Asthma is a chronic inflammatory disease that affects the airways in the lungs and mak...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCNTBdiscussed_in_filing Artificial Intelligence
topic_mentionCNTBdiscussed_in_filing Cybersecurity
topic_mentionCNTBdiscussed_in_filing Trusted Computing
topic_mentionCNTBdiscussed_in_filing Blockchain & Crypto
topic_mentionCNTBdiscussed_in_filing Regulation
topic_mentionCNTBdiscussed_in_filing Healthcare & Bio
topic_mentionCNTBdiscussed_in_filing Platform & Ecosystem
topic_mentionCNTBdiscussed_in_filing Sovereign & Government
topic_mentionCNTBdiscussed_in_filing Artificial Intelligence
topic_mentionCNTBdiscussed_in_filing Cybersecurity
topic_mentionCNTBdiscussed_in_filing Trusted Computing
topic_mentionCNTBdiscussed_in_filing Blockchain & Crypto
topic_mentionCNTBdiscussed_in_filing Regulation
topic_mentionCNTBdiscussed_in_filing Healthcare & Bio
topic_mentionCNTBdiscussed_in_filing Platform & Ecosystem
topic_mentionCNTBdiscussed_in_filing Sovereign & Government
topic_mentionCNTBdiscussed_in_filing Artificial Intelligence
topic_mentionCNTBdiscussed_in_filing Cybersecurity
topic_mentionCNTBdiscussed_in_filing Trusted Computing
topic_mentionCNTBdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001835268-26-000013EDGAR117K words
2025-03-312024-12-310001835268-25-000014EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001835268-25-000058EDGAR15K words
2025-08-132025-06-300001835268-25-000052EDGAR—
2025-05-152025-03-310001835268-25-000035EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001835268-26-000012EDGAR3K words
2026-03-300001835268-26-000006EDGAR—
2025-12-230001835268-25-000061EDGAR—
2025-11-120001835268-25-000057EDGAR—
2025-09-160001835268-25-000056EDGAR—
2025-08-130001835268-25-000051EDGAR—
2025-07-220001835268-25-000047EDGAR—
2025-07-210001835268-25-000044EDGAR—
2025-07-170001835268-25-000039EDGAR—
2025-07-090001628280-25-034551EDGAR—

72 total filings indexed. 57 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001835268
TickerCNTB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedE9

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3da4496462af3d5805687f9b0d26c77b572e63e467ba8a7b077496f9dba9db87
parent: 83f7ad9d902f887c2237eeceb94804ef9059492db2f3ca2580f59b41359d4a48
content hash: 465d4ab04da21e0bc09c1a1f3e83aefaebb428795d6465c4eab63b6a79fae76a
signed: 2026-04-13T04:44:25.067Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf